Nessan Bermingham, Venture partner at Atlas Venture
Nessan Bermingham, Venture partner at Atlas Venture
SBBI Seminar: THE PAST PRESENT AND FUTURE OF HUMAN GENOME EDITING
SBBI Seminar: THE PAST PRESENT AND FUTURE OF HUMAN GENOME EDITING
30 Mar 201812:00 PM – 1:30 PM
Harvard community only
Nessan Bermingham, PhD
Venture Partner; Former Chief Executive Officer, Intellia Therapeutics
Nessan is co-founder and was previously chief executive officer of Intellia Therapeutics.
He led Intellia from seed investment and incubation at Atlas Venture through its IPO
and the advancement of its gene editing platform toward clinical development. He has
over fifteen years of experience in life science investing across venture, secondary,
and public markets. Previously, Nessan was a partner at Atlas Venture, Omega Funds
and founder of Bio Equity Capital, a healthcare focused special situations firm. He
has been involved as founding CEO of a number of Life Sciences companies and has invested
in and supported biotech companies across Europe and N America.